Imiquimod
Imiquimod

10.13
Helps regulate local immune responses to support cell renewal on the skin.


Ingredient
Category
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Imiquimod
Reference Brand
Aldara
Product Origin
Generic Product
Reference Manufacturer
iNova Pharmaceuticals
Product Form
Cream
Regulatory Classification
Rx
Primary Category
Skin Care
Product Category
Immune Response Modifier
Pharmacological Class
Imidazoquinoline
Manufacturer Description
Utilized for genital warts and basal cell carcinoma to manage lesion removal and support immune recognition.
Mechanism of Action
The medication acts as an agonist at toll-like receptor 7. This stimulates the local production of cytokines, particularly interferon-alpha, which activates the immune system to recognize and destroy diseased cells and viral particles.
Route of Administration
Topical
Onset Time
2–4 weeks
Duration
8–16 weeks (treatment course)
Contraindications
Hypersensitivity to imiquimod
Severe Adverse Events
Severe skin ulceration, Flu-like symptoms, Angioedema — requires immediate medical attention
Common Side Effects
Redness, Itching, Burning
Uncommon Side Effects
Skin crusting, Swelling, Skin erosion
Drug Interactions
Alcohol
Pregnancy Safety Warnings
FDA Category C: Use with caution. Breastfeeding: Not recommended as safety data is limited.
Age Restrictions
Safety and efficacy established in pediatric patients 12 years and older for genital warts.
Storage Guidelines
Store at room temperature; do not freeze.
Related Products
Aldara, Efudix, Zyclara
Information related to Imiquimod is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
How to purchase Allergy Treatment Drugs - Deltacortril Generic